New Delhi: A multi-institutional study on dengue led by researchers at the Indian Institute of Science (IISc) shows how the virus causing the disease has evolved dramatically over the last few decades in the Indian subcontinent. Cases of dengue – a mosquito-borne viral disease – have steadily increased in the last 50 years, predominantly in … Read more
Chennai: Researchers from the Indian Institute of Technology Madras (IIT Madras) have developed an online open-source database called ‘Ab-CoV’ containing detailed information about all COVID-related antibodies identified so far, including the source of each antibody, and the viral protein(s) and virus strains they recognise. ‘Ab-CoV’ includes 1,780 coronavirus-related antibodies including 211 nanobodies, and contains more … Read more
In November 2020, when the first sero survey was conducted in the state, seroprevalence was at 32%. COVID-19 in Tamil Nadu: 87% of the people aged above 18 years in the southern state of Tamil Nadu have been found to have antibodies against novel coronavirus, according to the state’s health department. A seroprevalence survey held … Read more
New Research: Vaccination administered in the afternoon produces more antibodies in the body than those who have taken the dose in the morning, claims a recent observatory study published in the Journal of Biological Rhythms. The health workers produced more antibody levels when receiving vaccine doses in the afternoon compared to those who were inoculated … Read more
Nov. 9, 2021 — As the U.S. rounds out its second year of the pandemic, many people are trying to figure out just how vulnerable they may be to COVID-19 infection, and whether it’s finally safe to fully return to all the activities they miss. On an individual basis, the degree and durability of the … Read more
Oct. 4, 2021 — Antibody levels may wane after 7 months for people who got the Pfizer-BioNTech vaccine, according to a new study published on the bioRxiv preprint server. In the study, which hasn’t yet been peer-reviewed or formally published in a medical journal, researchers analyzed blood samples from 46 healthy young or … Read more
Infectious Diseases Society of America: “Monoclonal Antibodies.” The New England Journal of Medicine: “Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.” William Fales, MD, medical director, Michigan Department of Health and Human Services, Division of EMS and Trauma. Lindsay Petty, MD, infectious disease doctor, University of Michigan. Eli Lilly: “Emergency Use Authorization (EUA) for the … Read more
Most people who were infected by SARS-CoV-2 developed antibodies. The study revealed that antibody production was based on severity of symptoms A new study has found that those with severe and long-lasting Covid-19 symptoms are likely to have higher levels of antibody which is needed to fight against future infections. This new study from Rutgers … Read more
Spacing out doses boosts antibody levels, say researchers – who suggest eight weeks as the “sweet spot”. Source link
Director of CSIR’s Institute of Genomics and Integrative Biology and INSACOG Anurag Agarwal speaks to Anubhuti Vishnoi on the Sars-Cov-2 variants. On variants in India The B.1. 617.2 the sub lineage of B.1. 617 is rising faster than B.1.617.1. In some parts of the country, the B.1.117 (Kent variant) is still dominant like in Punjab … Read more